Trastuzumab-Mediated Cardiotoxicity and Its Preventive Intervention by Zingerone through Antioxidant and Inflammatory Pathway in Rats

Trastuzumab (TZB) is a new medicine, used to treat cancers of the breast and stomach. However, the cardiotoxic potential of this drug edges out its clinical advantages. The present study was designed to find out the effect of zingerone against trastuzumab-mediated cardiotoxicity in rats. In this stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Gyas, Alam, Mohammad Firoz, Alshahrani, Saeed, Almoshari, Yosif, Jali, Abdulmajeed M., Alqahtani, Saud, Khalid, Mohammad, Mir Najib Ullah, Shehla Nasar, Anwer, Tarique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221553/
https://www.ncbi.nlm.nih.gov/pubmed/37240920
http://dx.doi.org/10.3390/jpm13050750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221553/
https://www.ncbi.nlm.nih.gov/pubmed/37240920
http://dx.doi.org/10.3390/jpm13050750

Ejemplares similares